inner-banner-bg

Archives of Epidemiology & Public Health Research(AEPHR)

ISSN: 2833-4353 | DOI: 10.33140/AEPHR

Impact Factor: 1.98

Mini Review Article - (2022) Volume 1, Issue 2

Complete Genome Sequence of Multi-Drug Resistant Klebsiella Quasipneumoniae Isolated for The First Time from A Wastewater Treatment Plant in Slovenia

José Gonçalves 1,2,3 *, Tom Koritnik 1 *, Martin Bosilj 1 , Verica Mioc 1 , Marija Trkov 1 and Metka Paragi 1
 
1Department for Public Health Microbiology, National Laboratory for Health, Environment and Food, Ljubljana, Slovenia, Spain
2Institute of Sustainable Processes, Valladolid University, Dr. Mergelina s/n., 47011 Valladolid, Spain
3Department of Chemical Engineering and Environmental Technology, University of Valladolid, Dr. Mergelina, Spain
 
*Corresponding Author: José Gonçalves, Department for Public Health Microbiology, National Laboratory for Health, Spain Tom Koritnik, Institute of Sustainable Processes, Valladolid University, Dr. Mergelina s/n., 47011 Valladolid, Spain

Received Date: Oct 11, 2022 / Accepted Date: Oct 19, 2022 / Published Date: Nov 02, 2022

Copyright: ©Jose Goncalves and Tom Koritnik. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation: Jose Goncalves, Tom Koritnik, Martin Bosilj, Verica Mioc, and Marija Trkov, et al. (2022). Complete Genome Sequence of Multi-Drug Resistant Klebsiella Quasipneumoniae Isolated for The First Time from A Wastewater Treatment Plant in Slovenia. Archives of Epidemiology & Public Health Research. 1(2), 69-72.

Abstract

Objectives: This study reports the isolation and genomic characterization of two novel multidrug-resistant isolates of Klebsiella quasipneumoniae, isolated from a municipal wastewater treatment plant in Slovenia. Methods: Both genomes were sequenced on an Illumina MiSeq platform. De novo genome assembly was performed using Velvet 1.2.10. The genomes were annotated using RAST tool kit (RASTtk). The resistome was identified using tools available from the Center for Genomic Epidemiology. Results: High-quality contigs were obtained using and both belong to the MSLT ST 138. KB-61219-C generated 196 contigs and an estimated genome length of 5.958.270 bp. KB-161219-D generated 197 contigs and an estimated genome length of 5.955.847 bp. Conclusion: This study reports the isolation and genomic characterization of two novel multidrug-resistant isolates of Klebsiella quasipneumoniae, isolated from a municipal wastewater treatment plant in Slovenia.

Introduction

In recent years, the fate of antimicrobial resistance genes (ARGs) released to wastewaters has received increasing interest [1] and there is a worldwide consensus that raw municipal wastewater, treated effluent and wastewater sludge are reservoirs of ARGs and crucial hotspots for the evolution and spread of antibiot¬ic resistance [2]. Klebsiella quasipneumoniae is a common in¬testinal commensal bacterium that is widely distributed in the environment. It is an important human pathogen causing both nosocomial and community-acquired infections [3].

Infections caused by Carbapenemase-producing Enterobacteri¬aceae (CPE) are of greatest interest in clinical practice because carbapenems are often the last resort for antimicrobial action [4].

Klebsiella quasipneumoniae isolates KB-161219-C and KB- 161219-D were obtained from untreated and treated wastewater, respectively, in Ljubljana, Slovenia, in December 2019. DNA was extracted using the DNAeasy Blood & Tissue Kit (Qiagen, Netherlands) and quantified using the Qubit dsDNA HS assay Kit (Invitrogen, USA) in a Qubit 3.0 fluorometer (Invitrogen, USA), following the manufactures instructions. Sequencing li¬braries were prepared with the Nextera DNA Flex Library Prepa¬ration Kit (Illumina, USA) and barcoded with Nextera DNA CD indexes (Illumina, USA). The genomes were sequenced using the Miseq Reagent Kit V3 500 cycles (Illumina, USA) on a Mis¬eq sequencer (Illumina, USA).

High-quality contigs were obtained using Velvet 1.2.10 and both belong to the MSLT ST 138. KB-61219-C generated 196 contigs and an estimated genome length of 5.958.270 bp. KB- 161219-D generated 197 contigs and an estimated genome length of 5.955.847 bp. The complete genomes were annotated using RAST tool kit (RASTtk). KB-161219-C has 6.006 pro¬tein conding sequences (CDS), 76 transfer RNA (tRNA), and 4 ribossomal RNA (rRNA). The annotation included 1.063 hypo-thetical proteins and 4.943 protein with functional assignments. KB-161219-D contains 6.013 protein conding sequences (CDS), 76 transfer RNA (tRNA), and 4 ribossomal RNA (rRNA). The annotation included 1.067 hypothetical proteins and 4.946 pro¬tein with functional assignments. This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession numbers SAMN15818748 and SAMN15818747. As¬sembled contigs were submitted to ResFinder 4.0 in the web service of the Center for Genomic Epidemiology and results are summarized in [Table 1].

This study reports the isolation and genomic characterization of two novel multidrug-resistant isolates of Klebsiella quasipneu¬moniae, isolated from a municipal wastewater treatment plant in Slovenia. The detection and characterization of these isolates show the spread of pathogenic and multidrug-resistant strains into the environment, especially concerning due to fact that CPE harbour highly transferable and broad-spectrum resistance plas¬mids. This work highlights the need to monitor bacteria carrying beta-lactam resistance genes in the environment, food and clini¬cal settings, in order to better understand their impact and role in the transmission of ARGs [1-5].

Table 1: Antimicrobial resistance genes of Klebsiella quasipneumoniae using the tool ResFinder 4.0 in the web service of the Center for Genomic Epidemiology

Isolate

Resistance gene

Identity

Alignment Length/Gene Length

Coverage

Predicted Phe­notype

Accession

KB161219D

fosA5

93.33

420/420

99,7

Fosfomycin resis­tance

EU195449

aac(6’)-IIb

99.82

543/543

100,0

Aminoglycoside resistance

L06163

aac(3)-Ia

98.69

534/534

100,0

Aminoglycoside resistance

X15852

aadA2b

99.87

780/780

100,0

Aminoglycoside resistance

D43625

aac(6’)-Ib3

100.00

555/555

100,0

Aminoglycoside resistance

X60321

aadA1

99.62

792/792

100,0

Aminoglycoside resistance

JQ414041

blaOKP-B-18

99.65

860/861

99,8

Beta-lactam resis­tance

AM850920

blaOXA-10

99.88

801/801

100,0

Beta-lactam resis­tance

J03427

blaOXA-17

99.88

801/801

100,0

Beta-lactam resis­tance

DQ902344

blaGES-5

100.00

864/864

100,0

Beta-lactam resis­tance

DQ236171

oqxA

93.62

1176/1176

100,0

Quinolone resis­tance

EU370913

oqxB

95.53

3153/3153

100,0

Quinolone resis­tance

EU370913

aac(6’)-Ib-cr

99.61

519/519

100,0

Fluoroquinolone and aminoglyco­side resistance

EF636461

catB2

100.00

633/633

100,0

Phenicol resis­tance

AF047479

catA1

99.85

660/660

100,0

Phenicol resis­tance

V00622

 

cmlA1

99.92

1260/1260

100,0

Phenicol resis­tance

M64556

tet(B)

100.00

1206/1206

100,0

Tetracycline resistance

AP000342

sul1

100.00

840/840

100,0

Sulphonamide resistance

U12338

KB161219C

fosA5

93.33

420/420

99,7

Fosfomycin resis­tance

EU195449

aadA1

99.62

792/792

100,0

Aminoglycoside resistance

JQ414041

aadA2b

99.87

780/780

100,0

Aminoglycoside resistance

D43625

aac(3)-Ia

98.69

534/534

100,0

Aminoglycoside resistance

X15852

aac(6’)-IIb

99.82

543/543

100,0

Aminoglycoside resistance

L06163

aac(6’)-Ib3

100.00

555/555

100,0

Aminoglycoside resistance

X60321

catB2

100.00

633/633

100,0

Phenicol resis­tance

AF047479

catA1

99.85

660/660

100,0

Phenicol resis­tance

V00622

cmlA1

99.92

1260/1260

100,0

Phenicol resis­tance

M64556

oqxA

93.62

1176/1176

100,0

Quinolone resis­tance

EU370913

aac(6’)-Ib-cr

99.61

519/519

100,0

Fluoroquinolone and aminoglyco­side resistance

EF636461

oqxB

95.53

3153/3153

100,0

Quinolone resis­tance

EU370913

tet(B)

100.00

1206/1206

100,0

Tetracycline resistance

AP000342

sul1

100.00

840/840

100,0

Sulphonamide resistance

U12338

blaOKP-B-18

99.65

860/861

99,9

Beta-lactam resis­tance

AM850920

blaOXA-10

99.88

801/801

100,0

Beta-lactam resis­tance

J03427

blaGES-5

100.00

864/864

100,0

Beta-lactam resis­tance

DQ236171

blaOXA-17

99.88

801/801

100,0

Beta-lactam resis­tance

DQ902344

Funding

This work was funded by the Department for Public Microbiolo-gy, National Institute of Health, Environment and Food, Ljublja¬na, Slovenia and with the financial support from the Regional Government of Castilla y León and the FEDER program (proj¬ects CLU 2017-09, CL-EI-2021-07, UIC315 and VA266P20).

Competing interests

None declared.

Ethical approval

Not required.

References

  1. Lorenzo, P., Adriana, A., Jessica, S., Carles, B., Marinella, F., Marta, L., ... & Pierre, S. (2018). Antibiotic resistance in urban and hospital wastewaters and their impact on a re­ceiving freshwater ecosystem. Chemosphere, 206, 70-82.
  2. Liu, L., Su, J. Q., Guo, Y., Wilkinson, D. M., Liu, Z., Zhu,Y. G., & Yang, J. (2018). Large-scale biogeographical pat­terns of bacterial antibiotic resistome in the waterbodies of China. Environment international, 117, 292-299.
  3. Long, S. W., Linson, S. E., Ojeda Saavedra, M., Cantu, C., Davis, J. J., Brettin, T., & Olsen, R. J. (2017). Whole-ge-nome sequencing of human clinical Klebsiella pneumoniae isolates reveals misidentification and misunderstandings of Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae. Msphere, 2(4), e00290-17.
  4. McKenna, M. (2013). The last resort: health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics--one of the last drugs on the shelf. Nature, 499(7459), 394-397.
  5. Papp-Wallace, K. M., & Endimiani, A. (2011). taracila MA, Bonomo rA. Carbapenems: past, present, and future. Anti-microb Agents Chemother, 55, 4943-60.